Literature DB >> 23262079

Involvement of P2X(7) receptors in retinal ganglion cell death after optic nerve crush injury in rats.

Keigo Kakurai1, Tetsuya Sugiyama, Takuji Kurimoto, Hidehiro Oku, Tsunehiko Ikeda.   

Abstract

We investigated whether P2X(7) antagonists rescue retinal ganglion cells (RGCs) in culture and after optic nerve crush (ONC) injury. Rats were sacrificed 7 days after retrograde labeling of RGCs with 4',6-diamidino-2-phenylindole (DAPI), and the retinas were enzymatically dissociated in vitro and incubated with P2X(7) antagonists or agonists for 3 days. Adenosine triphosphate (ATP) and benzoylbenzoyl ATP were used as P2X(7) agonists, and oxidized ATP and brilliant blue G were used as P2X(7) antagonists. DAPI-positive and calcein-positive RGCs were counted to determine the number of living cells. We observed that RGCs were preserved when treated with P2X(7) antagonists, as compared with the controls. In contrast, P2X(7) agonists significantly decreased the number of viable RGCs. In vivo, P2X(7) antagonists at various doses were injected into the vitreous body immediately after ONC injuries in rats. Surviving RGCs were stained with anti-neuron-specific β-tubulin antibody in flat-mounted retinas. RGCs were observed to decrease to 61% of baseline 7 days after ONC injury, whereas RGCs were significantly preserved when P2X(7) antagonists were applied. When P2X(7) receptor expression was examined immunohistochemically in rat retinas after ONC, the retinal expression of the P2X(7) receptors was observed to be upregulated after ONC and peaked on day 3. Meanwhile, P2X(7) antagonists suppressed this upregulation. Collectively, these results suggest that P2X(7) antagonists prevent loss of RGCs after ONC, and that this protective effect is possibly mediated through suppressing the upregulation of retinal P2X(7) expression.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23262079     DOI: 10.1016/j.neulet.2012.11.060

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

Review 2.  Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Müller cells, lens, trabecular meshwork, cornea and lacrimal gland.

Authors:  Julie Sanderson; Darlene A Dartt; Vickery Trinkaus-Randall; Jesus Pintor; Mortimer M Civan; Nicholas A Delamere; Erica L Fletcher; Thomas E Salt; Antje Grosche; Claire H Mitchell
Journal:  Exp Eye Res       Date:  2014-08-20       Impact factor: 3.467

Review 3.  Purinergic signaling in the retina: From development to disease.

Authors:  Ana Lucia Marques Ventura; Alexandre Dos Santos-Rodrigues; Claire H Mitchell; Maria Paula Faillace
Journal:  Brain Res Bull       Date:  2018-11-17       Impact factor: 4.077

Review 4.  Brilliant Blue Dyes in Daily Food: How Could Purinergic System Be Affected?

Authors:  Leonardo Gomes Braga Ferreira; Robson Xavier Faria; Natiele Carla da Silva Ferreira; Rômulo José Soares-Bezerra
Journal:  Int J Food Sci       Date:  2016-10-19

5.  Characterization of the Circumlimbal Suture Model of Chronic IOP Elevation in Mice and Assessment of Changes in Gene Expression of Stretch Sensitive Channels.

Authors:  Da Zhao; Christine T O Nguyen; Vickie H Y Wong; Jeremiah K H Lim; Zheng He; Andrew I Jobling; Erica L Fletcher; Holly R Chinnery; Algis J Vingrys; Bang V Bui
Journal:  Front Neurosci       Date:  2017-02-10       Impact factor: 4.677

6.  P2X7 Receptor Mediates Spinal Microglia Activation of Visceral Hyperalgesia in a Rat Model of Chronic Pancreatitis.

Authors:  Pei-Yi Liu; I-Hui Lee; Ping-Heng Tan; Yen-Po Wang; Chia-Fen Tsai; Han-Chieh Lin; Fa-Yauh Lee; Ching-Liang Lu
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-07-22

Review 7.  Novel Therapeutics in Glaucoma Management.

Authors:  Claudio Bucolo; Chiara Bianca Maria Platania; Filippo Drago; Vincenza Bonfiglio; Michele Reibaldi; Teresio Avitabile; Maurizio Uva
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

8.  P2X₇ receptor activation may be involved in neuronal loss in the retinal ganglion cell layer after acute elevation of intraocular pressure in rats.

Authors:  Tetsuya Sugiyama; So Yeon Lee; Taeko Horie; Hidehiro Oku; Shinji Takai; Hidetoshi Tanioka; Yumi Kuriki; Shota Kojima; Tsunehiko Ikeda
Journal:  Mol Vis       Date:  2013-09-28       Impact factor: 2.367

9.  Role of P2X7 receptors in neuronal death in the retina.

Authors:  Tetsuya Sugiyama
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

10.  Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury.

Authors:  Francisco M Nadal-Nicolás; Caridad Galindo-Romero; Francisco J Valiente-Soriano; María Barberà-Cremades; Carlos deTorre-Minguela; Manuel Salinas-Navarro; Pablo Pelegrín; Marta Agudo-Barriuso
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.